Study of the hepatoprotective activity of pharmaceutical substance of plant origin in the form of a dry extract based on milk thistle, columns with stigmas of corn and peppermint

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. Liver diseases continue to be one of the most common in the clinic of internal diseases. The problem of alcoholic fatty liver disease, and especially due to the current pandemic of type 2 diabetes mellitus and obesity – non-alcoholic fatty liver disease, has become one of the leading world problems of modern medicine in recent years. In the treatment of these diseases, as well as in almost all other liver diseases, one of the leading places belongs to hepatoprotectors.

Objective: was to study the hepatoprotective activity of pharmaceutical substance of plant origin (PSPO) in the form of a dry extract based on the fruits of milk thistle, columns with stigmas of corn and peppermint leaves.

Material and methods. The study of the hepatoprotective activity of preparation was carried out on a model of toxic (tetrachloromethane) hepatitis.

Results. The data obtained indicate the presence in the test preparation of significant hepatoprotective activity comparable to the reference preparation.

Conclusion. The studied PSPO in the form of a dry extract based on milk thistle fruits, columns with stigmas of corn, peppermint leaves has a significant hepatoprotective activity that is not inferior to the reference preparation.

全文:

受限制的访问

作者简介

Bakhtiyor Imamaliev

«Med Standart» Research Center

编辑信件的主要联系方式.
Email: teokrat_1985@mail.ru
ORCID iD: 0000-0002-7526-5105

PhD in Pharmaceutical Sciences, Senior Sientific Researcher, Head of Scientific Center

乌兹别克斯坦, Karasarai St., 343, Tashkent, 100049

Nafisa Salimova

Tashkent Pharmaceutical Institute

Email: nafisaxon1993@inbox.ru
ORCID iD: 0000-0001-6325-1542

Assistant of the Chair of Pharmacology and Clinical Pharmacy

乌兹别克斯坦, Aibek St., 45, Tashkent, 100015

Rano Sultanova

Tashkent Pharmaceutical Institute

Email: r.kh.sultanova@gmail.com
ORCID iD: 0000-0002-3983-3419

PhD in Pharmaceutical Sciences, Associate Professor, Head of the Chair of Pharmacology and Clinical Pharmacy

乌兹别克斯坦, Aibek St., 45, Tashkent

Muzaffar Isadjanov

«Med Standart» Research Center

Email: muzaffarm_13@mail.ru
ORCID iD: 0000-0001-8458-3220

laboratory doctor

俄罗斯联邦, Karasarai St., 343, Tashkent, 100049

参考

  1. Oparin A.G., Lavrova N.V., Blagoveshchenskaya A.V. Hepatoprotectors: tactics of clinical use. Clinical pharmacology. Symposium. 2016; 1: 75–81 (in Ukraine).
  2. Reference Vidal. [Electronic edition]. Access mode: http://vidal.ru (in Russian).
  3. Bibik E.Yu., Shipilova N.V., Krivokolysko B.S., Semenido E.A., Burdeynaya A.A. Features of the pharmacological properties of modern hepatoprotectors. Morphological almanac named after V.G. Koveshnikov. 2019; 17 (4): 101–10 (in Ukraine).
  4. Dvornikova L.G., Turetskova V.F., Korenovsky Yu.V. Design of capsules with dry corn extract. Farmatsiya (Pharmacy). 2020; 69 (2): 39–43. https://doi.org/10/29296/25419218-2020-02-07 (in Russian).
  5. Prishchep T.P., Chuchalin V.S., Khoruzhaya T.G., Belova L.S., Fedoreev S.A., Vengerovsky A.I., Saratikov A.S. Rational dosage forms of new hepatoprotectors of plant origin. Farmatsiya (Pharmacy). 1999; 6: 33–4 (in Russian).
  6. Zhuravleva L.V., Krivonosova E.M. Comparative characteristics of hepatoprotective agents is the key to rational use. Modern gastroenterology. 2013; 4 (72): 93–101 (in Ukraine).
  7. Guidelines for pre-clinical study of medicinal products. Part 1. (by ed. A.N. Mironov). Moscow: Grief and K, 2012; 944 (in Russian).
  8. Gildikov D.I. Hepatoprotective and antioxidant effects of Mexidol-Vet® in an experiment on rats. Russian veterinary journal (Rossijskij veterinarnyj zhurnal). 2020; 5: 37–42 (in Russian).
  9. Kurmanova E.N., Ferubko E.V., Strelkova L.B., Panin V.P., Kurmanov R.K., Panina M.I. The hepatoprotective activity of Bupleurum aureum L. at the experimental model operation of liver pathology. Problems of biological, medical and pharmaceutical chemistry. 2018; 21 (8): 45−51. https://doi.org/10.29296/25877313-2018-08-07 (in Russian).
  10. Shulgau Z.T., Sergazy Sh.D., Krivoruchko T.N., Sagindykova B.A., Gulyayev A.Ye. Investigation of hepatoprotective properties of RN-13 RNA-containing drug with the modelof acute tetrahllormethane induced hepatitis in rats. Bulletin of SurSU. The medicine. 2017; 3 (33): 58–63 (in Russian).

补充文件

附件文件
动作
1. JATS XML
##common.cookie##